40 results on '"Baltacı S"'
Search Results
2. LB02 - RETRACTED: Grade heterogeneity in high grade urothelial carcinomas: Does it have an impact on the survival of patients with intermediate/high risk NMIBCr who received adequate adjuvan BCG therapy?
- Author
-
Karaburun, M.C., Serbes, E.D., Akpinar, C., Obaid, K., Gogus, C., Kiremitci, S., Enneli, D., Baltaci, S., and Suer, E.
- Published
- 2023
- Full Text
- View/download PDF
3. La dosis única de instilación intravesical postoperatoria inmediata de quimioterapia no es superior al lavado continuo con suero
- Author
-
Türkeri, L., primary, Karşıyakalı, N., additional, Aslan, G., additional, Akgül, M., additional, Baltacı, S., additional, Bolat, D., additional, Şahin, H., additional, Karabay, E., additional, İzol, V., additional, and Tinay, İ., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Öğrenme ve Belleğin Moleküler Biyolojisi: Öğrenirken ve Öğrendiklerimizi Depolarken Beynimizde Neler Yaşanıyor?
- Author
-
Baltacı, S. Buğra, primary
- Published
- 2019
- Full Text
- View/download PDF
5. A0996 - Oncological outcomes of patients with non-clear cell renal cell cancers: Subtypes of unclassified and translocation renal cell cancers
- Author
-
Gökalp, F., Celik, S., Sozen, T.S., Ozen, A.H., Aslan, G., Izol, V., Baltaci, S., Muezzinoglu, T., Akdogan, B., Suer, E., and Tinay, I.
- Published
- 2022
- Full Text
- View/download PDF
6. P121 Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer
- Author
-
Divrik, R.T., primary, Türkeri, L., additional, Şahin, A.F., additional, Akdoğan, B., additional, Ateş, F., additional, Çal, Ç., additional, and Baltacı, S., additional
- Published
- 2012
- Full Text
- View/download PDF
7. Surgical Repair of a Giant Renal Artery Aneurysm: A Case Report
- Author
-
Gyedu, A., Karakoyun, R., Baltacı, S., Yağcı, C., and Köksoy, C.
- Published
- 2008
- Full Text
- View/download PDF
8. S078: The prognostic affect of preoperative leucocytosis, neutrophil and lymphocyte count in patients who underwent radical cystectomy with diagnosis bladder cancer
- Author
-
Ozcan, C., Göğğş, C., Oztuna, D., Sğer, E., Gğlpinar, Ö., Telli, O., Öztğrk, E., and Baltaci, S.
- Published
- 2014
- Full Text
- View/download PDF
9. Management of Ureterosigmoidal Anastomotic Stricture by Balloon Dilatation
- Author
-
Safak, M., primary, Saglam, R., additional, Baltacı, S., additional, Adsan, Ö., additional, Sanlıdilek, U., additional, and Bedük, Y., additional
- Published
- 1991
- Full Text
- View/download PDF
10. RISK-ADAPTED SCREENING IN BLADDER CANCER AS A NEW STRATEGY IN BLADDER CANCER IS FEASIBLE USING A COMPUTER-BASED QUESTIONNAIRE, RISIKOCHECK V4.0, EVALUATED IN AN INTERNATIONAL MULTICENTRE TRIAL
- Author
-
Luedecke, G., Tuerker, P., Guenluesoy, B., Yildirim, A., Aslan, G., Mungan, A., Baltaci, S., Kaplan, M., Bozlu, M., Sahin, H., and Tuerkeri, L.
- Published
- 2008
- Full Text
- View/download PDF
11. DOES RENAL CAPSULAR INVASION HAVE ANY PROGNOSTIC VALUE IN LOCALISED RENAL CELL CARCINOMA
- Author
-
Suer, E., Ergun, G., Baltaci, S., and Beduk, Y.
- Published
- 2008
- Full Text
- View/download PDF
12. 860Penil length changes in men treated with combined hormone therapy and radiotherapy for locally advanced prostatic carcinoma
- Author
-
Haliloglu, A., Baltaci, S., and Yaman, O.
- Published
- 2005
- Full Text
- View/download PDF
13. 830Validation of 2001 partin tables in Turkey: A multicenter study
- Author
-
Eskicorapci, S., Karabulut, E., Türkeri, L., Baltaci, S., Cal, C., Toktas, G., Akpmar, H., Ozer, G., Sozen, S., Tokuc, R., Lekili, M., Soylu, A., Albayrak, S., Sahin, H., Alpar, R., and Özen, H.
- Published
- 2005
- Full Text
- View/download PDF
14. RE: INFLUENCE OF TUMOR STAGE, SIZE, GRADE, VASCULAR INVOLVEMENT, HISTOLOGICAL CELL TYPE AND HISTOLOGICAL PATTERN ON MULTIFOCALITY OF RENAL CELL CARCINOMA
- Author
-
Baltaci, S., Orhan, D., Soyupek, S., Bedük, Y., Tulunay, Ö., and Göğüs, O.
- Published
- 2001
- Full Text
- View/download PDF
15. RE: INFLUENCE OF TUMOR STAGE, SIZE, GRADE, VASCULAR INVOLVEMENT, HISTOLOGICAL CELL TYPE AND HISTOLOGICAL PATTERN ON MULTIFOCALITY OF RENAL CELL CARCINOMA
- Author
-
Wunderlich, Heiko, Zermann, Dirk-Henrik, Kosmehl, Hartwig, Schubert, Jörg, Baltaci, S., Orhan, D., Soyupek, S., Bedük, Y., Tulunay, Ö., and Göğüs, O.
- Published
- 2001
- Full Text
- View/download PDF
16. C 55 Urological evaluation of Behçet patients and the effect of colchicine on fertility
- Author
-
Sarica, K., Gürler, A., Baltaci, S., Özdiler, E., Dincel, C., and Süzer, O.
- Published
- 1993
- Full Text
- View/download PDF
17. Analysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group.
- Author
-
Teke K, Yılmaz H, Baltacı S, Akgül M, Şahin B, Türkeri L, Bozkurt O, Yücetaş U, Aslan G, Bolat D, İzol V, Özkan TA, and Eskiçorapçi S
- Abstract
Objective: To investigate the risk factors affecting cancer-specific survival (CSS) in nonresponsive disease to neoadjuvant chemotherapy (NAC) among patients with muscle-invasive bladder cancer (MIBC) who were treated with NAC and radical cystectomy (RC)., Methods: Patients with MIBC who underwent NAC and RC were retrospectively examined. By comparing clinical and pathological stages, patients whose pathological stage was lower than clinical stage were categorized as "NAC-responsive" and the remainder as "NAC-non-responsive." Apart from pathologic staging, variables compared between groups included age, gender, Eastern Cooperative Oncology Group (ECOG) score, clinical stages, NAC type and cycle number, durations between MIBC diagnosis and NAC initiation and RC, presence of hydronephrosis, number of lymph nodes removed, and variant histology of urothelial bladder cancer. CSS analysis was performed by construction of Kaplan-Meier survival curves and multivariable Cox regression was performed to identify the prognosticators in the NAC-non-responsive-group., Results: Ninety-two patients were included with a mean age was 61.5 ± 8.5 years, of whom 84.8% were men. The NAC regimen used was predominantly gemcitabine-cisplatin (88%) and the median cycle number was 4. Fifty-six (60.9%) patients were NAC-non-responsive. There was a significantly lower proportion of patients receiving ≥4 cycles (46.4% vs. 66.7%) and a higher rate of patients with ECOG score ˃1 (33.9% vs. 11.1%) in the NAC-non-responsive-group compared to the NAC-responsive-group (both P < 0.05). Other variables were similar between groups. In multivariable analysis, only ypN+ was found to be an independent prognosticator for CSS in NAC-non-responsive-group (HR: 2.725, CI95%:1.017-7.303)., Conclusion: Although higher ECOG scores and lower cycle numbers appears to be associated factors in NAC-non-responsive disease, only ypN(+) status was a prognosticator for CSS in this population., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
18. Grade Heterogeneity in High-Grade Urothelial Carcinomas: Does It Have an Impact on the Survival of Patients With Intermediate/High-Risk Nonmuscle-Invasive Bladder Cancer Who Received Adequate Adjuvant Bacillus Calmette-Guérin Therapy?
- Author
-
Karaburun MC, Kuz ED, Akpınar Ç, Obaid K, Göğüş C, Kiremitci S, Enneli D, Baltacı S, and Süer E
- Subjects
- Humans, Male, Retrospective Studies, Female, Aged, Middle Aged, Administration, Intravesical, Neoplasm Invasiveness, Aged, 80 and over, Neoplasm Recurrence, Local epidemiology, Neoplasm Recurrence, Local pathology, Progression-Free Survival, Survival Rate, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms mortality, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms therapy, BCG Vaccine therapeutic use, BCG Vaccine administration & dosage, Neoplasm Grading, Carcinoma, Transitional Cell pathology, Carcinoma, Transitional Cell mortality, Carcinoma, Transitional Cell drug therapy, Carcinoma, Transitional Cell therapy, Adjuvants, Immunologic therapeutic use
- Abstract
Purpose: We aimed to compare recurrence-free survival (RFS) and progression-free survival (PFS) of the patients with pure high-grade (HG) vs mixed-grade (MG) nonmuscle-invasive bladder cancer who received adequate bacillus Calmette-Guérin therapy., Materials and Methods: We conducted a retrospective cohort analysis using data from an institutional database. The study included patients diagnosed with HG nonmuscle-invasive bladder cancer at the initial transurethral resection specimen between 2010 and 2020. The initial transurethral resection specimens of all patients were reevaluated by a dedicated uropathologist. The percentage of low-grade tumor areas accompanying HG areas was determined for each case. Time-to-event analysis was performed using the Kaplan-Meier method. RFS and PFS rates were compared between groups., Results: Of the 203 patients enrolled in the study, 69 (34%) had MG tumors. Recurrence was observed in 41 out of 134 patients (30.6%) in the HG group and in 19 out of 69 patients (27.5%) in the MG group. The 36-month RFS rates were 69% (CI: 62-77) and 72% (CI: 62-83) for the HG-urothelial carcinoma (UC) and MG-UC groups, respectively. The RFS rates were similar between groups (log-rank, P = .58). Progression was observed in 22 out of 134 patients (16.4%) in the HG group and in 4 out of 69 patients (5.8%) in the MG group. The 36-month PFS rates were 84% (CI: 77-90) and 94% (CI: 89-100) for the HG-UC and MG-UC groups, respectively. The pure HG-UC group had a worse PFS than the MG-UC group (log-rank, P = .042). Multivariate analysis demonstrated that age and tumor grade were significant risk factors for the development of progression., Conclusions: The indication of MG-UC category separately from pure HG carcinomas in the pathology report seems to be an important issue that can guide patient management. In this way, both more accurate risk classification and more accurate patient counseling can be performed. More importantly, the treatment plan can be made more accurately. For more precise conclusions, our results should be supported by prospective studies with larger sample size.
- Published
- 2024
- Full Text
- View/download PDF
19. Relationship of Toll-Like Receptor 7, 9, and 10 Polymorphisms and the Severity of Coronavirus Disease 2019.
- Author
-
Bayyurt B, Baltacı S, Şahin NÖ, Arslan S, and Bakır M
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Adult, SARS-CoV-2 genetics, Genotype, Gene Frequency, Alleles, Case-Control Studies, COVID-19 genetics, COVID-19 virology, Toll-Like Receptor 7 genetics, Polymorphism, Single Nucleotide, Toll-Like Receptor 9 genetics, Genetic Predisposition to Disease, Severity of Illness Index, Toll-Like Receptor 10 genetics
- Abstract
Coronavirus disease 2019 (COVID-19) is a pandemic that is still affecting people and has caused many deaths. Toll-like receptors (TLRs) have an important role in the binding of disease agents to the host cell, disease susceptibility and severity, and host disease resistance. In this study, we investigated the frequencies of TLR7 (C.4-151 A/G), TLR9 (T-1486C and G2848A), and TLR10 (720A/C and 992T/A) single nucleotide polymorphisms in 150 cases with COVID-19 and 171 control samples. We also examined whether TLR7, TLR9, and TLR10 were related to COVID-19 severity. Furthermore, we analyzed the association between COVID-19 and some clinical parameters. Polymerase chain reaction based on restriction fragment length polymorphisms performed for the TLR7, TLR9, and TLR10 single nucleotide polymorphisms. TLR7 C.4-151 A/G G allele and GG genotype; TLR9 T-1486C C allele and TC, CC genotypes; and TLR10 720A/C C allele; TLR10 992T/A A allele and AA genotype frequencies were statistically significant in cases with COVID-19 compared with controls (P < 0.05*). In addition, there was a statistically significant difference in the distribution of TLR7, TLR9, and TLR10 allele and genotype frequencies between the severity groups (P < 0.05*). Our findings suggest that TLR7, TLR9, and TLR10 polymorphisms may be crucial for the clinical course and susceptibility to infection.
- Published
- 2024
- Full Text
- View/download PDF
20. "This Is a Disease" and "Disease Has No Sin": Discourse Constructions of Individuals With Obsessive-Compulsive Disorder With Regard to Being Diagnosed.
- Author
-
Baltacı S, Gençöz T, and Sarı S
- Subjects
- Humans, Obsessive-Compulsive Disorder diagnosis, Obsessive-Compulsive Disorder psychology
- Abstract
Obsessive-compulsive disorder (OCD) symptoms have different cultural images in society. Deconstructive psychology studies can contribute to understanding the dominant discourse surrounding these patients, given the prevalence of OCD. The objective of this study was to investigate the discourse of participants regarding "having/receiving a diagnosis of OCD" and the function of this discourse. The research approach was qualitative and language-based, specifically employing Lacanian Discourse Analysis (LDA) perspective. The possible questions and prompts were determined along with the research team, and seven semi-structured interviews were conducted with six participants diagnosed with OCD. The interviews explored how participants referred to their diagnosis, the language they used, and the function of this discourse. The findings revealed that participants diagnosed with OCD insistently used the term "disease" to explain their peculiar and distressing situations, referring to "medical discourse" with expressions such as "This is a disease" and "This disorder." Additionally, they often utilized "religious discourse" with the statements like "Disease has no sin" and "The sick and insane are exempt from their responsibilities." The findings of the current research indicated that when individuals with OCD "receive a name" through a recognized diagnosis, they experience a sense of recognition and validation for their OCD-related problems. Consequently, individuals diagnosed with OCD tend to find "legitimacy" for their irrational or unwanted thoughts and behaviors by taking comfort from their diagnosis. This study provides valuable insights into an understanding of patients with OCD. The findings are discussed in the context of their implications for both theoretical and applied research., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
21. Role of PD-1/PD-L1-mediated tumour immune escape mechanism and microsatellite instability in the BCG failure of high-grade urothelial carcinomas.
- Author
-
Salman FG, Kankaya D, Özakıncı H, Şahin Y, Kubilay E, Süer E, Hayme S, and Baltacı S
- Subjects
- Humans, Microsatellite Instability, Programmed Cell Death 1 Receptor genetics, BCG Vaccine therapeutic use, B7-H1 Antigen, Tumor Escape, Biomarkers, Tumor metabolism, Urinary Bladder Neoplasms genetics, Carcinoma, Transitional Cell genetics, Carcinoma, Transitional Cell pathology
- Abstract
Background: Intravesical BCG treatment fails inexplicably in 30%-45% of patients for high-grade nonmuscle-invasive bladder cancer (NMIBC). We aimed to investigate the role of PD-1/PD-L1 interaction on BCG failure of high-grade NMIBC and to identify biomarkers for predicting BCG responsive cases., Methods: Thirty BCG responsive and 29 nonresponsive NMIBCs were included in the study. Expressions of PDL1(SP-263), MSH2, MSH6, PMS2, and MLH1 were evaluated on pre- and post-BCG transurethral resection (TUR-B) specimens by immunohistochemistry. PD-L1(SP-263) expression was categorised as negative/low, high. DNA mismatch repair protein (MMR) expressions were classified as "reduced" if ≤30% of nuclei stained, "preserved" if >30% of nuclei stained. Microsatellite instability (MSI) testing was performed by PCR using five mononucleotide markers., Results: Reduced DNA MMR protein expression was found to be significantly higher in the pretreatment biopsies of BCG-responsive group than the BCG nonresponsive tumour group (p = 0.022). PD-L1 expression did not show any significant difference between the pre- and posttreatment TUR-B specimens of the BCG nonresponsive tumour group or between the pretreatment TUR-B specimens of BCG nonresponsive and the BCG responsive groups (p = 0.508, p = 0.708, respectively)., Discussion: Immune escape of tumour cells by PD-1/PD-L1 interaction does not seem to have any role in BCG failure of NMIBCs. Reduced MMR expression may help to determine cases that will respond well to BCG therapy. A better antitumour activity of BCG in NMIBCs with reduced MMR expression may be related to the ongoing accumulation of cancer neoantigens in correlation with increased tumour mutation load as a result of DNA repair defects.
- Published
- 2022
- Full Text
- View/download PDF
22. Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer.
- Author
-
Kubilay E, Akpinar Ç, Oǧuz ES, Araz MS, Soydal Ç, Baltacı S, Ürün Y, and Süer E
- Subjects
- Gallium Radioisotopes, Humans, Lymphatic Metastasis, Male, Neoplasm Staging, Prostate, Retrospective Studies, Tumor Burden, Positron Emission Tomography Computed Tomography, Prostatic Neoplasms
- Abstract
Objective: To evaluate the accuracy of Ga-68 prostate-specific membrane antigen positron-emission-tomography and computed-tomography(PSMA-PET/CT) in primary nodal staging of prostate cancer (PCa), and the predictive value of volumetric parameters derived from Ga-68- PSMA-PET/CT data in lymph node(LN) metastasis and correlation with histopathological and surgical outcomes., Materials and Methods: Seventy-seven patients with newly diagnosed, biopsy-proven PCa who underwent Ga-68-PSMA-PET/CT for primary staging of disease and underwent radical prostatectomy with extendend pelvic LN dissection were evaluated retrospectively. 2 experienced nuclear medicine specialists have retrospectively reviewed PET/CT images blinded to all histopathological and clinical data. Sensitivity, specificity, positive predictive value(PPV), and negative predictive value(NPV) for the detection of LN metastases were analyzed per-patient. Volumetric and semiquantitative PET parameters of the primary prostate lesions including SUVmax,metabolic tumor volume(MTV), and total lesion uptake(TLU) were measured and recorded., Results: Primary tumor SUVmax, MTV and TLU were found significantly higher in patients who were in higher ISUP Grade groups 3,4,5 after surgical treatment (P = 0.021,P = 0.049,P = 0.032, respectively). The sensitivity, specificity, PPV and NPV on LN metastasis detection of Ga-68-PSMA-PET/CT was found 60%, 91%, 82% and 78% respectively. Although the distribution of the measured primary tumor MTV and TLU values were higher in histopathologically proven LN metastasis positive patients compared to negative patients, only TLU was statistically significant(P = 0.023). Increase in primary tumor TLU values were correlated with higher pT stages and surgical margin positivity(P = 0.034)., Conclusion: Ga-68-PSMA-PET/CT is of clinically valuable for primary staging. Measuring and adding these 2 parameters in routine clinical evaluation may increase the prediction power of high-grade disease confirmed by surgery., Competing Interests: Conflict of Interest No conflict of interest was declared by the authors., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
23. Adjuvant Treatment Approaches after Radical Prostatectomy with Lymph Node Involvement.
- Author
-
Tavukçu HH, Erbatu O, Akdoğan B, İzol V, Yücetaş U, Sözen S, Aslan G, Şahin B, Tinay İ, Müezzinoğlu T, and Baltacı S
- Subjects
- Chemotherapy, Adjuvant, Humans, Lymph Node Excision, Lymph Nodes pathology, Lymphatic Metastasis pathology, Male, Prostate-Specific Antigen, Prostatectomy, Radiotherapy, Adjuvant, Prostatic Neoplasms drug therapy, Prostatic Neoplasms surgery, Seminal Vesicles pathology
- Abstract
Objective: The aim of this study was to evaluate the adjuvant treatment preferences and effects on disease progression in patients with pathologically positive lymph node prostate cancer., Methods: Patients who underwent radical prostatectomy from the prostate cancer database of the Turkish Urooncology Association with lymph node involvement were included in the study. Database includes prostate cancer patients from many experience Urooncology centers of Turkey. Adjuvant treatment approaches and the factors that effect the PSA recurrrence was analysed., Results: Postoperative median 2 (1-3) lymph nodes were found to be positive, and the median lymph node density was reported as 0.13 (0.07-0.25). Seventy-four percent of patients received adjuvant treatment postoperatively. Seventy four of the patients (46.54%) received hormonal therapy in combination with radiotherapy; 47 of them (29.55%) received only hormonal treatment and 20(12.57%) only received radiotherapy. The number of lymph nodes removed was less in the group requiring adjuvant treatment, and this group had a higher rate of surgical margin positivity and seminal vesicle invasion. In addition, adjuvant treatment group had a statistically significant higher lymph node density. There was no significant difference in Kaplan-Meier method comparing 5-year PSA recurrence-free survival in patients with and without adjuvant therapy. When the patient clustered as non-adjuvant, only hormonal therapy and hormonal therapy with radiotherapy, a significant survival advantage was found in the hormonal therapy with radiotherapy group compared to the other two groups (p=0.043)., Conclusion: No significant difference was found between two groups in terms of time until PSA recurrence during our follow-up. In subgroup analysis survival advantage was found in the hormonal therapy with radiotherapy group compared to non-adjuvant and only hormonal therapy groups.
- Published
- 2022
- Full Text
- View/download PDF
24. Does Switching Bacillus Calmette-Guerin Strains During Maintenance Therapy Affect the Outcome in Non-Muscle Invasive Bladder Cancer?
- Author
-
Süer E, Karaburun MC, Babayiğit M, Akpınar Ç, Gökçe Mİ, Gülpınar Ö, Türkölmez K, and Baltacı S
- Subjects
- Adjuvants, Immunologic adverse effects, Aged, Aged, 80 and over, BCG Vaccine adverse effects, Disease Progression, Female, Humans, Kaplan-Meier Estimate, Maintenance Chemotherapy, Male, Middle Aged, Neoplasm Invasiveness, Progression-Free Survival, Retrospective Studies, Urinary Bladder Neoplasms pathology, Adjuvants, Immunologic therapeutic use, BCG Vaccine therapeutic use, Mycobacterium bovis, Neoplasm Recurrence, Local pathology, Urinary Bladder Neoplasms drug therapy
- Abstract
Objective: To compare the patients who have received 1 type of BCG strain during maintenance therapy with patients treated with multiple BCG strains., Material and Methods: We reviewed 279 patients treated with BCG between January 2012 and May 2019, retrospectively. The primary endpoints of the study were recurrence-free survival (RFS) and progression-free survival (PFS) rates among patients receiving same BCG strain (Group-1) and multiple BCG strains (Group-2). Matching analysis was performed to balance the groups. The Kaplan-Meier method was used for estimating RFS and PFS. The difference between the 2 groups in terms of adverse effects was evaluated using the chi-square test., Results: A total of 225 (80.6 %) patients were treated with single BCG strain, and 54 (19.4 %) were treated with multiple BCG strains. Overall, recurrence and progression was observed in 86 (30.8%) and 38 (13.6%) patients, respectively. There was no significant difference between the 2 groups in terms of recurrence-free survival and progression-free survival on both without matching and with propensity score match analysis (log rank; P=.760 and P=.559, P=.533 and P=0509 for non-match and matched analysis respectively). Most of the patients in both groups experienced BCG therapy related side effects, but there was no statistically significant difference between groups (P=.235/.833)., Conclusions: Switching the BCG strain because of unavailability of the induction strain does not decrease the effectiveness of the treatment. When it is not possible to reach the starting BCG strain, treatment can be safely continued with any available strain., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Perioperative adverse events and functional outcomes following open and robot-assisted prostatectomy in patients over age 70.
- Author
-
Sancı A, Özkaya MF, Oguz ES, Gokce Mİ, Süer E, Gülpinar O, Baltacı S, and Turkolmez K
- Subjects
- Aged, Humans, Male, Prostatectomy adverse effects, Retrospective Studies, Treatment Outcome, Prostatic Neoplasms surgery, Robotics
- Abstract
Aim: To evaluate the safety (perioperative adverse events) of robot-assisted radical prostatectomy (RARP) and functional outcomes (continence and erectile dysfunction) of open and robotic radical prostatectomy in elderly patients., Methods: The data of patients (≥70 years old) who underwent open retropubic radical prostatectomy (ORRP) and RARP within the period from November 2014 to February 2019 were evaluated retrospectively. The perioperative adverse events and the functional outcomes of both surgical approaches were evaluated., Results: A total of 149 men (59.3%) underwent ORRP, and 102 men (41.7%) underwent RARP. The mean age in the ORRP group was 73.6 ± 3.2 years, and that in the RARP group was 74.7 ± 4.1 years. The rate of grade 3 or higher (major) complications for the ORRP group was 4.7% (7 out of 149), and that for the RARP group was 4.9% (5 out of 102). The 24 months full continence and potency rates of the ORRP and RARP groups were 78.5% vs 79.4% and 21.8% vs 22.6%, respectively., Conclusion: The perioperative adverse events are similar in elderly patients undergoing ORRP and in RARP. The continence rates are favourable and reasonable, although the potency rates are low in elderly men who underwent prostatectomy. The results of the present study may be useful for surgeons in their decision making and counselling of elderly patients., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
26. Individual-risk-score for urinary tract malignancy in patients with microscopic hematuria.
- Author
-
Sancı A, Özkaya MF, Kubilay E, Gokce Mİ, Süer E, Gülpinar O, Baltacı S, and Turkolmez K
- Subjects
- Female, Humans, Male, Retrospective Studies, Risk Factors, Sensitivity and Specificity, Hematuria etiology, Urologic Neoplasms complications, Urologic Neoplasms epidemiology
- Abstract
Aim: To determine the patients who can be safely exempted from undergoing unnecessary diagnostic procedures for microscopic hematuria (MH) evaluation by using the developed individual-risk-scoring system., Materials and Methods: The patients who underwent a complete urological evaluation for MH were identified retrospectively. The risk factors for urinary malignancy which defined in the 2020 American Urological Association/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction guidelines were recorded for each patient. Multivariable logistic regression was performed to establish a predictive risk-scoring system. The odds ratios obtained as a result of the logistic regression analysis were scored., Results: A total of 1461 patients who had undergone a complete urological evaluation for MH were identified. The urinary malignancy rate was 3.4% (50 of the 1461 patients). According to the odds ratios, age >40 was calculated as 1 point; male gender, 2 points; smoking history, 4 points; presence of occupational risk factor, 1 point; and presence of macroscopic hematuria, 2 points. For the cut-off risk score, 5 points was found to be the most appropriate score according to the sensitivity and specificity levels. The patients with risk scores of 5 points or lower were considered to be in the low-risk group for urinary tract malignancy., Conclusion: The patients with a risk score of 5 points or above require complete urological evaluation. The results of the present study may reduce the number of patients undergoing unnecessary urological evaluation., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
27. Comparison of Microscopic Hematuria Guidelines as Applied in 1018 Patients With Microscopic Hematuria.
- Author
-
Sancı A, Oktar A, Gokce MI, Süer E, Gülpinar O, Gögüs C, Baltacı S, and Turkolmez K
- Subjects
- Aged, Humans, Middle Aged, Practice Guidelines as Topic, Retrospective Studies, Risk Factors, Guideline Adherence statistics & numerical data, Hematuria diagnosis
- Abstract
Objective: To compare the 2012 American Urological Association (AUA) and 2020 AUA/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) microscopic hematuria (MH) guidelines as applied in 1,018 patients with MH, to confirm of risk groups and to investigate the natural history of patients with MH., Materials and Methods: Patients who had undergone a complete urological evaluation for MH according to the 2012 AUA MH guidelines were identified retrospectively. All the patients were then classified into low-, intermediate-, or high-risk for urinary tract malignancy according to the updated 2020 AUA/SUFU MH guidelines, for a second evaluation. The results of the first and second evaluations using the previous 2012 AUA and updated 2020 AUA/SUFU MH guidelines, respectively, were then compared., Results: A total of 1018 patients with MH were identified. The urinary tract malignancy rate was 3.3% (34 of the 1,018 patients). According to the 2020 AUA/SUFU MH guidelines, there were 218 patients (21.4%) in the low-risk group, 447 patients (43.9%) in the intermediate-risk group, and 353 patients (34.6%) in the high-risk group. All the 34 patients with malignancy were from the intermediate- or high-risk group who require further urological evaluation. There was no patient with newly developed urinary tract malignancy at the median follow-up time of 28 months (12-58)., Conclusion: The use of the updated 2020 AUA/SUFU MH guidelines may reduce the number of diagnostic procedures without compromising the diagnosis of life-threatening malignant lesions., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
28. In the Age of Immunotherapy, How Can We Translate the CARMENA Results into Practice?
- Author
-
Yekedüz E, Süer E, Utkan G, Baltacı S, and Ürün Y
- Subjects
- Humans, Immunotherapy
- Published
- 2021
- Full Text
- View/download PDF
29. [Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
- Author
-
Büyüktuna SA, Hasbek M, Çelik C, Ünlüsavuran M, Avcı O, Baltacı S, Fırtına Topcu K, and Elaldı N
- Subjects
- Adult, Aged, Aged, 80 and over, Animals, Anti-Bacterial Agents pharmacology, Female, Humans, Male, Middle Aged, Reproducibility of Results, Retrospective Studies, Risk Factors, Sheep, Carbapenems pharmacology, Drug Resistance, Bacterial, Intensive Care Units statistics & numerical data, Klebsiella Infections epidemiology, Klebsiella Infections microbiology, Klebsiella Infections mortality, Klebsiella pneumoniae drug effects, Pneumonia
- Abstract
Klebsiella pneumoniae is the cause of complicated and difficult-to-treat nosocomial infections such as sepsis, urinary tract infection, catheter related infections, pneumonia and surgical site infections in intensive care units. The biggest problem in infections with K.pneumoniae is that treatment options are limited due to multiple antibiotic resistance and consequently the increased morbidity and mortality. The widespread and improper use of carbapenems can lead to epidemics that are difficult to control, especially in intensive care units because of the acquired resistance to this group of antibiotics. Outbreaks and sporadic cases caused by carbapenem resistant K.pneumoniae (CRKP) species have been reported all over the world in recent years with increased frequency. The aim of this study was to determine the risk factors related to carbepenem resistance and mortality caused by K.pneumoniae infections in a university hospital anesthesia intensive care unit. The study was conducted between January 1st, 2016, and December 31st, 2018. Retrospective data were obtained from the patient and laboratory-based surveillance records. Adult patients (≥ 18 years) with K.pneumoniae growth in the blood, urine, abscess and tracheal aspirate samples collected 48 hours after admission to the intensive care unit were considered as the relevant infection locus-related agent and treated with antibacterial therapy. Clinical samples collected from patients were inoculated onto 5% sheep blood and eosin-methylene-blue (EMB) agar except the blood samples. Blood samples were cultured in blood culture bottles and incubated in an automated system. Gram staining was performed for the samples showing growth signal within five days and then inoculated onto 5% sheep blood and EMB agar media and were incubated for 18-24 hours at 35.5-37°C. Identification of the isolates was performed using Bruker IVD MALDI Biotyper 2.3 (Bruker Daltonik GmbH, Bremen, Almanya) based on "matrix-assisted laser desorption/ionization time-of-mass spectrometry (MALDI-TOF MS)". K.pneumoniae isolates were identified by obtaining reliability scores of 2.0 and above in the study. Antibiotic susceptibility tests were performed with Phoenix 100 (BD, New Jersey, ABD) automated system. Interpretations were made according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. Combination disk diffusion test and polymerase chain reaction based tests were used to show the presence of carbapenemase in CRKP isolates. A total of 88 patients with K.pneumoniae infection were included in the study. The mean age of the patients was 74 ± 15 (range= 21-93) years and 60.2% were female. CRKP was detected in 32 patients (36.4%) and carbapenem-sensitive K.pneumoniae (CSKP) was detected in 56 patients. The presence of OXA-48 was found to be 68.8% in the carbapenem screening test performed by combination disc method in patients with CRKP. Multivariate logistic regression analysis showed that previous use of colistin [Odds ratio (OR)= 19.108; 95% confidence interval (CI)= 2.027-180.133; p= 0.010] and aminoglycoside (OR= 12.189; 95% CI= 1.256-118.334; p= 0.031) was an independent risk factor in terms of CRCP among the patients with K.pneumoniae infection. The 28-day mortality rates were 71.9% in the CRKP group (23/32) and 37.5% in the CSKP group (21/56). Presence of CRKP in terms of 28-day mortality (OR= 5.146; 95% CI= 1.839-14.398; p= 0.002) was an independent risk factor. The data obtained in this study will guide for conducting effective and continuous surveillance studies and implementing rational antibiotic programs to prevent the increase in CRKP.
- Published
- 2020
- Full Text
- View/download PDF
30. Should we rely on Doppler ultrasound for evaluation of testicular solid lesions?
- Author
-
Esen B, Yaman MÖ, and Baltacı S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Atrophy, Biomarkers, Tumor blood, Child, Child, Preschool, Humans, Male, Middle Aged, Retrospective Studies, Testicular Neoplasms pathology, Testis pathology, Tumor Burden, Young Adult, Orchiectomy methods, Testicular Neoplasms blood supply, Testicular Neoplasms diagnostic imaging, Testicular Neoplasms surgery, Ultrasonography, Doppler, Color
- Abstract
Purpose: Colour Doppler ultrasound (CDUS) is the main radiologic tool to evaluate scrotal masses and intratesticular-vascularised solid lesions are mostly considered malign lesions. Objective of this trial is determine ratio of benign lesions in patients with hypervascularised solid intratesticular lesions., Material and Method: Patients who underwent radical orchiectomy due to hypervascularised intratesticular solid lesions detected in CDUS are evaluated retrospectively. Those with previous testicular cancer history and inguinal/scrotal surgeries were excluded from the study. All patients are evaluated for age, preoperative testicular atrophy, multicentricity, echotexture and size of solid lesions, preoperative tumor markers (AFP, bHCG and LDH), and postoperative pathology results. Two tailed p value test was used to evaluate numeric parameters and Fisher's exact test was used to evaluate non-numeric parameters., Results: A total of 117 patients with a mean age of 35.9 (5-86) were included to the study. Mean size of solid lesions was 4.39 cm. Seven patients had subcentimeter (subcm) lesions. 101 patients had hypoechoic, ten patients had isoechoic and six patients hyperechoic solid lesions. Preoperatively 60 patients (51.2%) had at least one tumor marker elevated. Postoperative pathology examination resulted to; 21 patients (17.9%) had benign lesions. Elevation of tumor markers, palpability, hypoechoic texture and larger size of the solid lesion were found to be parameters that predict malignancy., Conclusion: Benign incidence of vascular testicular solid lesions detected with scrotal ultrasound with colour Doppler is greater than expected. In patients with smaller, non-palpable lesions without elevated tumor markers, treatment options other than radical orchiectomy such as testicular sparing surgery should be considered.
- Published
- 2018
- Full Text
- View/download PDF
31. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin.
- Author
-
Baltacı S, Bozlu M, Yıldırım A, Gökçe Mİ, Tinay İ, Aslan G, Can C, Türkeri L, Kuyumcuoğlu U, and Mungan A
- Subjects
- Administration, Intravesical, Disease Progression, Disease-Free Survival, Female, Humans, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local pathology, Secondary Prevention methods, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms pathology, Adjuvants, Immunologic administration & dosage, BCG Vaccine administration & dosage, Neoplasm Recurrence, Local prevention & control, Urinary Bladder Neoplasms prevention & control, Urinary Bladder Neoplasms surgery
- Abstract
Objectives: To evaluate the effect of the interval between the initial and second transurethral resection (TUR) on the outcome of patients with high-risk non-muscle-invasive bladder cancer (NMIBC) treated with maintenance intravesical Bacillus Calmette-Guérin (BCG) therapy., Patients and Methods: We reviewed the data of patients from 10 centres treated for high-risk NMIBC between 2005 and 2012. Patients without a diagnosis of muscle-invasive cancer on second TUR performed ≤90 days after a complete first TUR, and received at least 1 year of maintenance BCG were included in this study. The interval between first and second TUR in addition to other parameters were recorded. Multivariate logistic regression analysis was used to identify predictors of recurrence and progression., Results: In all, 242 patients were included. The mean (sd, range) follow-up was 29.4 (22.2, 12-96) months. The 3-year recurrence- and progression-free survival rates of patients who underwent second TUR between 14 and 42 days and 43-90 days were 73.6% vs 46.2% (P < 0.001) and 89.1% vs 79.1% (P = 0.006), respectively. On multivariate analysis, the interval to second TUR was found to be a predictor of both recurrence [odds ratio (OR) 3.598, 95% confidence interval (CI) 1.885-8.137; P = 0.001] and progression (OR 2.144, 95% CI 1.447-5.137; P = 0.003)., Conclusions: The interval between first and second TUR should be ≤42 days in order to attain lower recurrence and progression rates. To our knowledge, this is the first study demonstrating the effect of the interval between first and second TUR on patient outcomes., (© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
32. Do blood groups have effect on prognosis of patients undergoing radical cystectomy?
- Author
-
Süer E, Özcan C, Gökçe I, Gülpınar Ö, Göğüş C, Türkölmez K, Baltacı S, and Bedük Y
- Subjects
- Aged, Carcinoma secondary, Cystectomy, Disease-Free Survival, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate, Urinary Bladder Neoplasms pathology, ABO Blood-Group System blood, Carcinoma blood, Carcinoma surgery, Rh-Hr Blood-Group System blood, Urinary Bladder Neoplasms blood, Urinary Bladder Neoplasms surgery
- Abstract
Purpose: The purpose of the study was to investigate the effect of ABO blood groups and Rhesus (Rh) factor on prognosis of patients undergoing radical cystectomy., Materials and Methods: In this study, total number of 290 patients who underwent radical cystectomy between January 1990 and September 2012 were evaluated retrospectively. Patients were grouped as O and non-O according to ABO antigens; also positive and negative according to Rh factor. Parameters such as age, sex, stage, lymph node involvement and positive surgical margins were investigated. Disease-free and overall survival rates have been compared. Multivariate analysis were performed to determine independent prognostic factors., Results: A total of 260 (89.7 %) male and 30 (10.3 %) female patients participated in the study. Mean follow-up was 37.7 ± 18.9 months. A total of 180 patients were non-O (62.1 %),while the 110 patients had the blood group O (37.9 %). The number of Rh positive and negative patients were 247 (85.2 %) and 43 (14.8 %), respectively. According to the univariate and multivariate analyses, ABO blood groups and Rh factor did not exhibit any significant impact on overall and disease-specific survival., Conclusion: ABO blood group and Rh factor were not associated with the prognosis of bladder cancer patients who underwent radical cystectomy. However, prospective studies are needed in larger patient series for further evaluations.
- Published
- 2014
- Full Text
- View/download PDF
33. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
- Author
-
Suer E, Mermerkaya M, Gülpınar Ö, Afandiyev F, Baltacı S, Türkölmez K, and Bedük Y
- Subjects
- Adult, Antineoplastic Agents pharmacology, Bleomycin pharmacology, Cisplatin pharmacology, Creatinine blood, Etoposide pharmacology, Glomerular Filtration Rate drug effects, Humans, Male, Retrospective Studies, Young Adult, Antineoplastic Agents administration & dosage, Bleomycin administration & dosage, Cisplatin administration & dosage, Etoposide administration & dosage, Kidney drug effects, Kidney physiopathology, Neoplasms, Germ Cell and Embryonal drug therapy, Neoplasms, Germ Cell and Embryonal physiopathology, Testicular Neoplasms drug therapy, Testicular Neoplasms physiopathology
- Abstract
Purpose: We assessed the effects of the number of cisplatin, etoposide and bleomycin cycles on long-term renal function., Materials and Methods: A total of 157 patients with primary testicular germ cell tumors were treated between 1995 and 2013, of whom 113 (72%) received chemotherapy as the primary intervention. Data were collected retrospectively. The estimated glomerular filtration rate was determined using the Modification of Diet in Renal Disease (MDRD) formula based on pretreatment and last followup visit serum creatinine measurements. Patients who did not receive chemotherapy were compared to those who received cisplatin based chemotherapy. The chemotherapy group was also divided into 3 subgroups according to the number of chemotherapy cycles (2, 3, or 4 or more)., Results: At the last followup visit serum creatinine and the estimated glomerular filtration rate significantly differed between the chemotherapy and nonchemotherapy groups. The decrease in the median estimated glomerular filtration rate was significantly greater in the chemotherapy than the nonchemotherapy group (p<0.001). New onset stage 3 chronic kidney disease was observed in 19 patients (12.1%) in the chemotherapy group, including 0%, 5.9%, 13.8% and 20.9% who received 0, 2, 3, or 4 or more chemotherapy cycles, respectively. Except for the difference between the nonchemotherapy group and the 2-cycle chemotherapy group the differences between the groups in new onset chronic stage 3 kidney disease were statistically significant., Conclusions: Patients with testicular tumors who received cisplatin based chemotherapy showed a significant decrease in the estimated glomerular filtration rate and a significant increase in new onset stage 3 chronic kidney disease compared to patients who received no cycle. However, in patients at high risk with stage I nonseminomatous germ cell tumor who elected 2 cycles of cisplatin, etoposide and bleomycin the chemotherapy had no statistically significant effect on these parameters compared to those in patients who received no chemotherapy., (Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
34. Effect of type 2 diabetes mellitus on prognosis of nonmetastatic renal cell cancer.
- Author
-
Süer E, Oztürk E, Gülpınar O, Kayış A, and Baltacı S
- Abstract
Purpose: We evaluated the prognostic value of type 2 diabetes mellitus (DM) in patients treated surgically for localized renal cell carcinoma (RCC)., Materials and Methods: Between 1995 and 2011, 588 patients with renal tumor diagnoses were treated surgically and 492 patients with pathologically confirmed nonmetastatic RCC diagnoses were included in the study. The associations of clinical and pathologic parameters with a type 2 DM diagnosis were evaluated. Kaplan-Meier estimations for disease-specific survival (DSS) and overall survival (OS) were generated according to type 2 DM diagnosis, and the log-rank test was used to compare survival according to the variables., Results: The mean age of the patients was 56.7±12 years (range, 15 to 84 years; median, 58 years) and the mean length of follow-up was 35.9±28 months (range, 1 to 145 months; median, 34.3 months). Of the 492 patients, 62 (12.6%) had a diagnosis of DM at the time of surgery (group I) and 430 did not have DM (group II). The mean age and the incidence of clear cell RCC histological subtype were significantly higher in group I than in group II (p<0.001 and p=0.036, respectively). Although DSS and OS were lower in group I, this difference was not significant. Type 2 DM was not detected as an independent prognostic factor for DSS and OS., Conclusions: This study investigated the role and effect of DM on the prognosis of localized RCC that was treated surgically. The present study did not detect DM as an independent prognostic factor for RCC.
- Published
- 2013
- Full Text
- View/download PDF
35. Serum testosterone levels, testis volume, and the risk of prostate cancer: are these factors related?
- Author
-
Haliloğlu AH, Gökçe İ, Özcan C, Baltacı S, and Yaman Ö
- Abstract
Objective: Inconclusive results have been published in the literature regarding the relationship between free and total serum testosterone levels and prostate cancer. We investigated the relationship between total and free serum testosterone levels, testes volume, and prostate cancer in our patient population., Material and Methods: Total and free serum testosterone levels and serum PSA levels were recorded for 102 consecutive patients. All of the patients underwent transrectal ultrasonography-guided prostate biopsy due to an abnormal digital rectal examination finding and/or a serum PSA level of >4.0 ng/mL. All of the transrectal and testis US examinations and prostate biopsies were performed by the same radiologist. The testis length, width, and height were measured from transverse and longitudinal gray scale images, and the testis volume was calculated., Results: Prostate cancer was detected in 32 of 102 patients (31.3%) who underwent prostate biopsy (prostate cancer group). The remaining patients had benign histopathological findings (prostate cancer-free group). The prostate cancer and benign histology groups were compared for age, total and free testosterone, PSA values, and testis volume. The patients with prostate cancer were found to have a higher mean age (p=0.04). There were no significant differences in serum PSA levels, free or total testosterone levels, or testis volumes between the two groups (p>0.05). A binary logistic regression analysis showed that neither free nor total testosterone was a predictor of prostate cancer (p=0.315 and p=0.213, respectively). Only age was found to be a significant risk factor for the development of prostate cancer (p=0.02)., Conclusion: Our study failed to show a relationship between total or free serum testosterone levels, testis volume, and the risk of prostate cancer. Therefore, monitoring serum testosterone levels for prostate cancer prediction does not appear to add an advantage over PSA screening.
- Published
- 2013
- Full Text
- View/download PDF
36. Is there a role of the enhancement degree of the lesion on computerized tomography for the characterization of renal tumors?
- Author
-
Kutman K, Süer E, Bedük Y, Oztürk E, Gülpınar O, Gökçe I, and Baltacı S
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Adenoma, Oxyphilic diagnostic imaging, Adenoma, Oxyphilic pathology, Carcinoma, Renal Cell diagnostic imaging, Carcinoma, Renal Cell pathology, Kidney Neoplasms diagnostic imaging, Kidney Neoplasms pathology, Tomography, X-Ray Computed methods
- Abstract
Purpose: We determined the role of tumor enhancement on dynamic enhanced computerized tomography for differentiating pathological characteristics., Materials and Methods: A total of 149 patients with renal tumor underwent dynamic enhanced computerized tomography at our university from June 2007 to November 2011. Tumors were treated surgically and pathological evaluation was done. Precontrast and postcontrast HU values, and the difference were recorded. Postcontrast HU evaluations were done at the nephrographic phase of the procedure. Tumor HU values were compared according to histological subtype, tumor grade and pathological stage., Results: Mean ± SD patient age was 57 ± 13 years and mean tumor size was 4.8 ± 2.7 cm. Postcontrast HU and contrast difference values were significantly lower in the malignant group. A cutoff HU value of 138 HU (mean AUC 0.893 ± 0.027, 95% CI 0.84-0.94) differentiated renal cell cancer from oncocytoma with 88% sensitivity and 87% specificity. Low and high grade cases demonstrated similar precontrast and postcontrast HU, and contrast difference values. These enhancement parameters were significantly lower for higher stage (pT2-3) renal cell cancer than for pT1. We detected higher postcontrast values (mean 62 ± 14 vs 56 ± 39 HU, p = 0.011) and contrast difference values (mean 92 ± 15 vs 82 ± 42 HU, p = 0.034) for high grade than for low grade renal cell cancer in patients with tumors 4 cm or less., Conclusions: The degree of enhancement on computerized tomography helps differentiate tumor characteristics. These outcomes may help the clinician with prognostic evaluation and may augment the role of computerized tomography in therapeutic planning., (Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
37. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
- Author
-
Süer E, Özcan C, Baltacı S, Gülpınar Ö, Burgu B, Haliloğlu A, and Bedük Y
- Subjects
- Adult, Aged, Carcinoma, Transitional Cell pathology, Disease Progression, Female, Humans, Male, Middle Aged, Multivariate Analysis, Neoplasm Recurrence, Local pathology, Proportional Hazards Models, Risk Factors, Time Factors, Treatment Outcome, Urinary Bladder Neoplasms pathology, Carcinoma, Transitional Cell surgery, Neoplasm Recurrence, Local surgery, Reoperation methods, Urinary Bladder Neoplasms surgery
- Abstract
Purpose: We evaluated the risk factors for residual tumor detection after transurethral resection of bladder tumors (TURBT) in patients with newly diagnosed high-grade T1 transitional cell carcinoma of the bladder., Patients and Methods: Overall 132 patients underwent TURBT for primary bladder tumors and were diagnosed as high-grade T1 bladder cancer. Patients with incomplete resections were excluded from the study. Clinical and pathologic characteristics of the patients were compared and multivariate analysis was performed to determine independent prognostic factors., Results: Residual tumor was demonstrated in 57 (43.1%) of the patients. The residual tumor rate was significantly lower in patients with solitary tumors, tumors <3 cm in diameter, muscle presence in the initial TURBT pathologic sample and treated by an expert surgeon. In patients with solitary bladder tumors, tumors at the dome and posterior wall of the bladder exhibited higher rates of residual tumor (p < 0.0001). The time elapsed between first and second TURBT was significantly shorter in patients without residual tumor compared to patients with residual tumor at second TURBT (32.6 ± 9.1 vs. 39.3 ± 10.9 days, respectively, p = 0.001). Multivariate analysis demonstrated that time elapsed between first and second TURBT is the most important parameter for residual tumor detection., Conclusion: Our study revealed that multiple tumors, tumors >3 cm in size, absence of detrusor muscle in the initial TURBT specimen, TURBT performed by trainees and finally, as a new finding, prolonged interval between first and second TURBT are independent predictors for residual tumor detection in patients with high-grade T1 tumors., (© 2013 S. Karger AG, Basel.)
- Published
- 2013
- Full Text
- View/download PDF
38. Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer.
- Author
-
Divrik RT, Türkeri L, Şahin AF, Akdoğan B, Ateş F, Çal Ç, and Baltacı S
- Subjects
- Aged, Aged, 80 and over, Biopsy, Bone Neoplasms secondary, Chi-Square Distribution, Disease Progression, Humans, Logistic Models, Male, Middle Aged, Multivariate Analysis, Neoplasm Grading, Predictive Value of Tests, Prostate-Specific Antigen blood, Prostatic Neoplasms immunology, Prostatic Neoplasms pathology, Retrospective Studies, Risk Assessment, Risk Factors, Therapeutics, Time Factors, Turkey, Androgen Antagonists therapeutic use, Antineoplastic Agents, Hormonal therapeutic use, Bone Neoplasms drug therapy, Drug Resistance, Neoplasm, Prostatic Neoplasms drug therapy
- Abstract
Purpose: We tried to establish the predictive factors influencing the initial response, as well as its duration, and time to castration resistance (CR) for primary advanced prostate cancer (PC) with bone metastasis., Methods: We evaluated all patients initially receiving androgen deprivation therapy (ADT) for primary advanced PC with bone metastasis. A total of 982 patients with complete medical records available for analysis from 18 centers were included in this study. Age, initial PSA, Gleason score (GS) and extent of bone involvement (EBI) were recorded in a database., Results: Among all the patients, 896 (91.2%) responded to ADT initially. Pretreatment PSA and EBI were significant predictors in the multivariate model. Among the 659 patients who progressed into a CR state, the mean duration of response was 22.4 months. There was a significant correlation between the CR state and nadir PSA (nPSA) level and time to nPSA. Pretreatment PSA, EBI, GS, highest tumor volume in biopsy cores (%), number of positive biopsy cores, percent positive biopsy cores and time to nPSA were proven to be significant to predict a nPSA. Pretreatment PSA, GS and EBI were statistically significant predictors of PSA normalization in multivariate analysis. The limitation of the study depends on the retrospective design and a model was developed for low standardization as a result of using multicenter data. The patients enrolled in this study were from a relatively long period of time (1989-2008)., Conclusions: The results of this study indicate that it is possible to predict the initial response to ADT by pretreatment PSA levels and EBI, while the duration of response can be reflected by a multitude of clinical factors including nPSA, TTnPSA, percent positive cores, biopsy GS and EBI., (Copyright © 2011 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF
39. Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy.
- Author
-
Aydogdu O, Gokce MI, Burgu B, Baltacı S, and Yaman O
- Subjects
- Chi-Square Distribution, Humans, Male, Middle Aged, Organ Size drug effects, Organ Sparing Treatments methods, Penile Erection drug effects, Penile Erection physiology, Penis drug effects, Penis innervation, Prospective Studies, Prostatectomy adverse effects, Tadalafil, Time Factors, Carbolines therapeutic use, Penis anatomy & histology, Phosphodiesterase 5 Inhibitors therapeutic use, Prostatectomy rehabilitation
- Abstract
Objective: To evaluate the change in penile size r bilateral nerve sparing retropubic radical prostatectomy (BNSRRP) and possible effect of Tadalafil., Materials and Methods: A total of 65 patients underwent BNSRRP and they were evaluated prospectively for a whole year of follow-up. The patients were randomized to control without rehabilitation (Group 1) or Tadalafil rehabilitation group (Group 2). The patients were evaluated at months 3, 6 and 12 postoperatively for erectile function, penile measurements (flaccid penile length, penile length at maximum erection, penile circumference at flaccid status, and penile circumference at maximum erection), penile abnormalities and general health status. Statistical analysis was performed by Chi-Square test and significance was defined as p value < 0.05., Results: In Group 1 there was significant decrease in penile measurements at month 3 compared to preoperative measurements. There was decrease in all parameters at month 6 compared to month 3 but only the decrease in penile length at maximum erection was significant. There were no significant differences between postoperative months 6 and 12 for all measurements. In Group 2 there was a tendency to decrease in all measurements at month 3 compared to baseline. There was no significant difference for penile measurements between postoperative 3rd and 6th months and between 6th month and the first year., Conclusion: Although further large sampled trials are needed to describe the possible positive effect of tadalafil or other PDE5-I 's on penile size after BNSRRP, tadalafil rehabilitation is effective in preserving penile size especially in the early postoperative period after BNSRRP.
- Published
- 2011
- Full Text
- View/download PDF
40. The role of adjuvant chemotherapy in patients with locally advanced (pT3, pT4a) and/or lymph node-positive bladder cancer.
- Author
-
Reşorlu B, Türkölmez K, Ergün G, Baltacı S, Göğüş C, and Bedük Y
- Subjects
- Adult, Aged, Aged, 80 and over, Chemotherapy, Adjuvant, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Retrospective Studies, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms pathology
- Abstract
Objective: To report the long-term follow up of patients with locally advanced bladder cancer treated with either adjuvant chemotherapy with gemcitabine/cisplatin (GC) or methotrexate, vinblastine, epirubicin, and cisplatin (MVEC) or no additional treatment after radical cystectomy, to examine various survival endpoints and factors associated with long-term survival., Patients and Methods: Seventy-eight patients undergoing radical cystectomy for pathologic stage T3, T4 or lymph node-positive (N+) bladder cancer were divided to observation group (46 patients) and adjuvant chemotherapy group (32 patients). Data were obtained for recurrence free (RFS) and overall survival (OS)., Results: One-, 2- and 5-year RFS rates were 74, 56.8 and 51.1% for chemotherapy arm, whereas these ratios were 50.6, 31 and 27.6% for control arm, respectively (P = 0.032). RFS rates were significantly better in patients with lymph node-negative disease than in those with positive lymph nodes for control arm (P = 0.007), but for the chemotherapy arm there was no statistical difference between patients with lymph node-negative and -positive disease (P = 0.28). Mean OS and RFS times were 31.03 and 28.4 months for chemotherapy arm, while they were 22.17 and 18.09 months for control arm, respectively (P = 0.142, P = 0.196). On multivariate analysis, lymph node metastasis and adjuvant chemotherapy remained significant independent prognostic factors for cancer-specific survival., Conclusions: Bladder cancer is chemosensitive, and using adjuvant chemotherapy is likely to improve the outcome of local treatment and to decrease the rates of distant metastases.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.